HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC DETERMINATION OF BISACODYL INPHARMACEUTICAL DOSAGE FORMS MARKETED IN AUSTRALIA

Authors
BRADSHAW KM BURNETT J SIDHU AS
Citation
Km. Bradshaw et al., HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC DETERMINATION OF BISACODYL INPHARMACEUTICAL DOSAGE FORMS MARKETED IN AUSTRALIA, Journal of pharmaceutical and biomedical analysis, 13(11), 1995, pp. 1355-1362
Citations number
7
Categorie Soggetti
Pharmacology & Pharmacy
Journal title
Journal of pharmaceutical and biomedical analysis → ACNP
ISSN journal
07317085
Volume
13
Issue
11
Year of publication
1995
Pages
1355 - 1362
Database
ISI
SICI code
0731-7085(1995)13:11<1355:HLDOBI>2.0.ZU;2-1
Abstract
HPLC methods have been developed for the assay of bisacodyl in various pharmaceutical forms. The extraction procedures are simple and the HP LC conditions separate bisacodyl from its degradation products. The ch romatography was performed using a Merck LiChrospher RP-select B colum n, a mobile phase of 55% acetonitrile/45% 0.05 M KH2PO4 and detection by UV at 214 nm.